• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Schrodinger Inc (NQ: SDGR )

    18.68 -0.10 (-0.53%)
    Streaming Delayed Price Updated: 12:08 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Schrodinger Inc

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Why Shares of Schrödinger Were Up Today
    The company delivered a nice earnings surprise. 
    Via The Motley Fool
    3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
    From Schrödinger, Inc.
    Via Business Wire
    Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
    Via Benzinga
    4 Analysts Have This to Say About Schrodinger
    Via Benzinga
    Earnings Scheduled For February 28, 2023
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
    Via Benzinga
    3 AI Stocks to Buy for the Future of Automation
    Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy. 
    Via InvestorPlace
    Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger, Inc.
    Via Business Wire
    Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
    From Schrödinger Inc.
    Via Business Wire
    Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
    From Schrödinger
    Via Business Wire
    Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
    Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a... 
    Via Talk Markets
    Schrödinger to Present at SVB Securities Global Biopharma Conference
    From Schrödinger
    Via Business Wire
    Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
    Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in... 
    Via Talk Markets
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
    From Schrödinger, Inc.
    Via Business Wire
    Why These 7 Healthcare Stocks Could Soar in 2023
    These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
    Via InvestorPlace
    7 Drug Stocks That Will Soar in 2023
    These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
    Via InvestorPlace
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger, Inc.
    Via Business Wire
    Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
    Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
    Via Benzinga
    Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
    From Schrödinger
    Via Business Wire
    Stocks That Hit 52-Week Lows On Monday
      During Monday's session, 49 companies made new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 72 companies hit new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
    From Schrödinger
    Via Business Wire
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference
    From Schrödinger
    Via Business Wire
    Yelp, Twilio, Atlassian, And Other Big Losers From Friday
    U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
    Gainers 
    Via Benzinga
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.